Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Elvitegravir. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | METTL3 | Q86U44 | 1/20 | 0.98 |
| ▸ | PLA2G4A | P47712 | 5/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | EGFR | P00533 | 4/20 | 0.35 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | CMA1 | P23946 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Elvitegravir SCHEMBL726251 | 0.99 | METTL3 (1.00) | METTL3PLA2G4AMAPTGAATP53 | |
| Elvitegravir SCHEMBL13225651 | 0.99 | METTL3 (1.00) | METTL3PLA2G4AMAPTGAATP53 | |
| Elvitegravir SCHEMBL29623981 | 0.99 | METTL3 (1.00) | METTL3PLA2G4AMAPTGAATP53 | |
| Elvitegravir SCHEMBL726252 | 0.99 | METTL3 (1.00) | METTL3PLA2G4AMAPTGAATP53 | |
| Elvitegravir SCHEMBL1050769 | 0.98 | METTL3 (0.98) | METTL3PLA2G4AMAPTGAATP53 | |
| Elvitegravir SCHEMBL2280863 | 0.94 | METTL3 (0.89) | METTL3PLA2G4AMAPTGAATP53 | |
| SCHEMBL4366707 | 0.93 | METTL3 (0.88) | METTL3PLA2G4AMAPTGAATP53 | |
| Elvitegravir SCHEMBL31577400 | 0.93 | METTL3 (0.88) | METTL3PLA2G4AMAPTGAATP53 | |
| SCHEMBL1104875 | 0.93 | METTL3 (0.88) | METTL3PLA2G4AMAPTGAAEGFR | |
| SCHEMBL19829420 | 0.93 | METTL3 (0.88) | METTL3PLA2G4AMAPTGAAEGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011004389-A2 | AN IMPROVED PROCESS FOR THE PREPARATION OF ELVITEGRAVIR | MATRIX LABORATORIES LTD (IN) | 2011-01-13 | — | — | WO | disclosed |